Search

Your search keyword '"Kristin M. Sheffield"' showing total 55 results

Search Constraints

Start Over You searched for: Author "Kristin M. Sheffield" Remove constraint Author: "Kristin M. Sheffield" Topic medicine.disease Remove constraint Topic: medicine.disease
55 results on '"Kristin M. Sheffield"'

Search Results

1. Study of patient characteristics, treatment patterns, EGFR testing patterns and outcomes in real-world patients with EGFRm+ non-small cell lung cancer

2. Real-world treatment patterns and outcomes of abemaciclib for the treatment of HR+, HER2− metastatic breast cancer

3. HSR21-051: Treatment Outcomes Among HR+/HER2- Advanced/Metastatic Breast Cancer Patients Receiving CDK 4 & 6 Inhibitors in a United States Clinical Practice Setting

4. Real-world survival outcomes of heavily pretreated patients with refractory HR+, HER2−metastatic breast cancer receiving single-agent chemotherapy—a comparison with MONARCH 1

5. Primary tumor location and survival in colorectal cancer: A retrospective cohort study

6. Abstract P2-08-12: Initial real world treatment patterns and outcomes of Abemaciclib for the treatment of HR+,HER2- metastatic breast cancer

7. HSR19-077: Primary Tumor Location (PTL) and Survival Outcomes in a Real World Cohort of KRAS Wild-Type (WT) Metastatic Colorectal Cancer (mCRC) Patients in the United States

8. Abstract P6-18-19: Real-world survival of heavily pretreated patients with refractory HR+, HER2- metastatic breast cancer receiving single-agent chemotherapy - A comparison with MONARCH 1

9. Abstract P2-08-38: Influence of prognostic factors on outcomes among metastatic breast cancer patients treated with CDK4&6 inhibitors in routine clinical practice

10. Predicting optimal treatment regimens for patients with HR+/HER2- breast cancer using machine learning based on electronic health records

11. Development and validation of coding algorithms to identify patients with incident lung cancer in United States healthcare claims data

12. Minimization of olaratumab drug waste using real-world data

13. MS3 PREDICTING OPTIMAL TREATMENT REGIMENS FOR HR+/HER2- BREAST CANCER BASED ON ELECTRONIC HEALTH RECORDS USING RANDOM FOREST

14. Perceptions of overdetection of breast cancer among women 70 years of age and older in the USA: a mixed-methods analysis

15. Surgeon and Facility Variation in the Use of Minimally Invasive Breast Biopsy in Texas

16. PREOP-Gallstones

17. KRAS mutation as a prognostic factor and predictive factor in advanced/metastatic non-small cell lung cancer: A systematic literature review and meta-analysis

18. Impact of liver-directed therapy in colorectal cancer liver metastases

19. Trajectory of care and use of multimodality therapy in older patients with pancreatic adenocarcinoma

20. Cost-Effectiveness of Elective Laparoscopic Cholecystectomy Versus Observation in Older Patients Presenting with Mild Biliary Disease

21. Trends in Treatment and Survival in Older Patients Presenting with Stage IV Colorectal Cancer

22. Evaluating comparative effectiveness with observational data

23. Analysis of venous thromboembolic events after saphenous ablation

24. Receipt of Cancer Screening Is a Predictor of Life Expectancy

25. The effect of depression on stage at diagnosis, treatment, and survival in pancreatic adenocarcinoma

26. Hospital and Medical Care Days in Pancreatic Cancer

27. PS02.15 Evaluating the Uptake of Newly Marketed Drugs Using Real-World Data: An Example of Anti-PD-1s in Advanced Non-Small Cell Lung Cancer

28. Colonoscopist and Primary Care Physician Supply and Disparities in Colorectal Cancer Screening

29. Gallstone pancreatitis in older patients: Are we operating enough?

30. Implementation of a Critical Pathway for Complicated Gallstone Disease: Translation of Population-Based Data into Clinical Practice

31. End-of-life care in Medicare beneficiaries dying with pancreatic cancer

32. Resection Benefits Older Adults with Locoregional Pancreatic Cancer Despite Greater Short-Term Morbidity and Mortality

33. PS02.18 Characterization of Patients with KRAS-Mutated Advanced Non-Small Cell Lung Cancer (NSCLC) in a Community Practice Setting

34. Overall survival (OS) in patients (pts) with advanced hepatocellular carcinoma (HCC) and elevated alpha-fetoprotein (AFP): A real-world retrospective study

35. Factors associated with delayed gastric emptying after pancreaticoduodenectomy

36. Potentially inappropriate screening colonoscopy in Medicare patients: variation by physician and geographic region

37. Physician follow-up and observation of guidelines in the post treatment surveillance of colorectal cancer

38. Quality of post-treatment surveillance of early stage breast cancer in Texas

39. MINI01.19: Cost Analysis of Pemetrexed-Platinum with Maintenance vs. Paclitaxel-Carboplatin-Bevacizumab with Maintenance in Patients with Lung Cancer

40. Variation in the Use of Intraoperative Cholangiography during Cholecystectomy

41. Population-Based Analysis of Venous Thrombotic Events Following Saphenous Ablation

42. Surveillance of pancreatic cancer patients after surgical resection

43. 415 Patients with Adenosquamous Carcinoma of the Pancreas: A Population-Based Analysis of Prognosis and Survival

45. Neighborhood Context and Cognitive Decline in Older Mexican Americans: Results From the Hispanic Established Populations for Epidemiologic Studies of the Elderly

46. PS38. Increased Rate of Myocardial Infarction with Carotid Endarterectomy Under General Anesthesia: A Population-Based Study

47. Mo1575 Cost-Effectiveness of Elective Cholecystectomy vs. Observation in Older Patients Presenting With Mild Biliary Disease

49. Association Between Cholecystectomy With vs Without Intraoperative Cholangiography and Risk of Common Duct Injury

Catalog

Books, media, physical & digital resources